INDRAYANI BIOTECH LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/02/2025 ,inter alia, to consider and approve the unaudited financial results (Standalone and Consolidated) of the company for the quarter and nine months ended 31-12-2024 and any other business. A Board meeting for considering the said financial results was conducted on 14-02-2025 for which due intimation was given on 10-02-2025. That Board meeting could not consider said financial results since the financial statements of the material subsidiaries could not be consolidated due to unforeseencircumstances. The said financial results is being considered at an adjourned meeting to be held on 27-02-2024. While giving this intimation to Stock Exchange there is no provision to choose adjourned meeting in the given descriptions hence we have chosen Board meeting rescheduled in the description. Therefore we request you to kindly take note of the adjourned Board meeting.
Indrayani Biotech Ltd. Press Release Feb 26 2025
Filed with BSE · · 1 page · English
Release
Earlier from Indrayani Biotech
- Indrayani Biotech Ltd. Press Release Feb 14 2025
- Indrayani Biotech Ltd. Press Release Feb 10 2025
- Indrayani Biotech Ltd. Press Release Jan 20 2025
- Indrayani Biotech Ltd. Press Release Jan 02 2025
- Indrayani Biotech Ltd. Press Release Dec 17 2024
Later from Indrayani Biotech
- Indrayani Biotech Ltd. Press Release Feb 27 2025
- Indrayani Biotech Ltd. Press Release Feb 28 2025
- Indrayani Biotech Ltd. Press Release Mar 25 2025
- Indrayani Biotech Ltd. Press Release Mar 26 2025
- Indrayani Biotech Ltd. Press Release Mar 27 2025
Follow Indrayani Biotech into a list and get an email when it puts out news.
Follow Indrayani Biotech